RxDoctor Payments Data

Son Nguyen, MD

Urology · Merriam, KSNPI 1588695241

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (43.5%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Medivation LLC. at 43.5% of the total. Reporting peaked in 2023 at $14,687 and has fallen 94.2% since, to $852 in 2025. Among urology clinicians in KS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,227in general payments, 2019–2025

Across 471 payments — averaging $57.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medivation LLC.$12K
  • Pfizer$4K
  • Coloplast$3K
  • Palette Life Sciences, Inc.$1K
  • AbbVie$993
  • Astellas Pharma US Inc$982
  • plus $5K from 54 others
$6,380,699in research payments, 2019–2025

Across 487 payments — averaging $13,102 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medivation LLC.$3.5M
  • Pfizer$2.8M
  • Dendreon Pharmaceuticals LLC$58K
  • Ferring Pharmaceuticals AS$20K
  • Ferring International Pharmascience Center US$20K

What the payments were for

  • Consulting fees$11,85044%
  • Speaking & faculty fees$2,65010%
  • Travel & lodging$2,5829%
  • Food & beverage$9,15734%
  • Education$9884%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,227 in reported general payments places this provider in the 90th percentile of 111 urology providers in Kansas.

See all urology providers in Kansas

Medicare billing

Part B allowed, 2024
$331,447
Medicare patients
736
Services billed
7,326

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XtandiEnzalutamide15$199,503
MyrbetriqMirabegron60$64,605
GemtesaVibegron61$47,031
OrgovyxRelugolix12$32,823
Tamsulosin Hcl765$15,420
Dutasteride381$14,171
Silodosin86$6,785
Trospium Chloride ErTrospium Chloride31$6,026
Trospium Chloride78$5,660
Solifenacin Succinate74$5,460
Methenamine Hippurate58$5,436
Trimethoprim47$4,326
Potassium Citrate ErPotassium Citrate19$2,554
Cephalexin237$2,308
Tolterodine Tartrate ErTolterodine Tartrate35$1,858

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncXtandi, Myrbetriq$982$264,10975 claims
Sumitomo Pharma America, Inc.Gemtesa, Orgovyx$120$79,85573 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 111 urology providers in Kansas.

Other urology in Merriam

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →